| Issue Date | Title | Author(s) |
| 2015-03-09 | Better informing decision making with multiple outcomes cost-effectiveness analysis under uncertainty in ost-disutility space | McCaffrey, N; Agar, M; Harlum, J; Karnon, J; Currow, D; Eckermann, S |
| 2019-01-01 | Economic evaluation of the randomised, double-blind, placebo-controlled study of subcutaneous ketamine in the management of chronic cancer pain | McCaffrey, N; Flint, T; Kaambwa, B; Fazekas, B; Rowett, D; Currow, DC; Hardy, J; Agar, MR; Quinn, S; Eckermann, S |
| 2017 | Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care A Randomized Clinical Trial | Agar, M; Lawlor, P; Quinn, S; Draper, B; Caplan, G; Rowett, D; Sanderson, C; Hardy, J; Le, B; Eckermann, S; McCaffrey, N; Devilee, L; Fazekas, B; Hill, M; Currow, D |
| 2020-10-31 | Health-related quality of life in patients with inoperable malignant bowel obstruction: secondary outcome from a double-blind, parallel, placebo-controlled randomised trial of octreotide. | McCaffrey, N; Asser, T; Fazekas, B; Muircroft, W; Agar, M; Clark, K; Eckermann, S; Lee, J; Joshi, R; Allcroft, P; Sheehan, C; Currow, DC |
| 2013-01-01 | Is home-based palliative care cost-effective? An economic evaluation of the palliative care extended packages at home (PEACH) pilot | McCaffrey, N; Agar, M; Harlum, J; Karnon, J; Currow, D; Eckermann, S |
| 2014-04-15 | Preliminary development and validation of a new endof-life patient-reported outcome measure assessing the ability of patients to finalise their affairs at the end of life | McCaffrey, N; Skuza, P; Breaden, K; Eckermann, S; Hardy, J; Oaten, S; Briffa, M; Currow, D |
| 2012-10-10 | Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain | Hardy, J; Quinn, S; Fazekas, B; Plummer, J; Eckermann, S; Agar, M; Spruyt, O; Rowett, D; Currow, DC |
